Intravenous bisphosphonates

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2015
01220072015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
The renal status of patients with bone metastases secondary to solid tumors and their treatment with nephrotoxic agents is not… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
2014
2014
OBJECTIVES To analyze whether oxidative stress (OS) changes are present in patients with bisphosphonate-related osteonecrosis of… (More)
Is this relevant?
2014
2014
Three bone-targeted agents (BTAs) are approved in the USA for prevention of bone complications among solid tumor patients with… (More)
  • table 1
  • table 2
  • table 3
  • table 3
Is this relevant?
2014
2014
AIM To determine the plasma and saliva levels of IL-6 in patients with bisphosphonate-related osteonecrosis of the jaws (BRONJ… (More)
  • table 1
  • table 2
  • table 3
  • table 5
Is this relevant?
2013
2013
Cancer patients with bone metastases (BMets) are predisposed to skeletal complications. Bone-targeted therapies such as denosumab… (More)
  • table 1
  • table 2
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Review
2013
Review
2013
192 Background: Bone is a common site of metastatic involvement in patients (pts) with prostate cancer (PC). Bony metastases… (More)
Is this relevant?
2012
2012
PURPOSE Atypical femur fractures represent a potential complication of chronic oral bisphosphonate therapy in women with… (More)
Is this relevant?
2011
2011
PURPOSE The etiology of osteonecrosis of the jaw is poorly understood, but preferential mandibular uptake of intravenous… (More)
  • figure 1
  • table 1
Is this relevant?
2009
2009
1035 Background: Intravenous bisphosphonates (IV BPs) are safe and effective in reducing skeletal related events in MBC. The… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
PURPOSE Denosumab, a fully human monoclonal antibody to receptor activator of nuclear factor-kappaB ligand, suppresses bone… (More)
Is this relevant?